BLRX

BioLineRX

21 hedge funds and large institutions have $4.6M invested in BioLineRX in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$2.77M
2 -$1.14M
3 -$543K
4
O
OrbiMed
New York
-$114K
5
Morgan Stanley
Morgan Stanley
New York
-$91K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.84M
2
$1.08M
3
$673K
4
$295K
5
$124K
6
$108K
7
$103K
8
$90K
9
$72K
10
$51K
11
$42K
12
$36K
13
$33K
14
$25K
15
$15K
16
$9K
17
$3K
18
$1K
19
$33
20
21
22
23
24